原发性免疫缺陷病和脊髓性肌萎缩症临床特点及新生儿早期联合筛查实践

doi:10.11852/zgetbjzz2022-0657

中国儿童保健杂志 ›› 2022, Vol. 30 ›› Issue (7): 697-701.DOI: 10.11852/zgetbjzz2022-0657

• 专家笔谈 • 下一篇

原发性免疫缺陷病和脊髓性肌萎缩症临床特点及新生儿早期联合筛查实践

杨茹莱

浙江大学医学院附属儿童医院遗传与代谢科国家儿童健康与疾病临床医学研究中心,国家儿童区域医疗中心,浙江杭州 310052

收稿日期:2022-05-26 修回日期:2022-06-05 发布日期:2022-07-25 出版日期:2022-07-10
作者简介:杨茹莱(1963-),女,浙江人,主任医师,学士学位,主要研究方向为儿童保健、新生儿遗传性疾病筛诊治及管理。
基金资助:
浙江省重点研发项目(2021C03099);国家重点研发计划(2018YFC1002700 )

Clinical characteristics and neonatal early combined screening practice of primary immunodeficiency disease and spinal muscular atrophy

YANG Ru-lai

Department of Genetics and Metabolism,Children's Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health,National Children's Regional Medical Center,Hangzhou,Zhejiang 310052, China

Received:2022-05-26 Revised:2022-06-05 Online:2022-07-10 Published:2022-07-25

摘要/Abstract

摘要： 原发性免疫缺陷病(PID)及脊髓性肌萎缩症(SMA)均是由基因突变引起的能严重影响儿童健康甚至导致死亡的遗传性出生缺陷,早期发现和及时诊断治疗是影响预后的关键,新生儿筛查是目前实现早期诊断和干预的有效手段。近年来部分国家和地区已将SMA和PID中最为严重的重症联合免疫缺陷病(SCID)和最常见的B细胞缺乏症X连锁无丙种球蛋白血症(XLA)纳入新生儿筛查范围。浙江省在国内首次开展对SCID、XLA和SMA三种遗传性疾病的新生儿早期联合筛查实践,极大地提高了筛查效率,使出生缺陷三级预防关口前移,有助于显著改善患者的预后、提高生活质量、降低死亡率。

关键词: 原发性免疫缺陷病, 重症联合免疫缺陷病, X连锁无丙种球蛋白血症, 脊髓性肌萎缩症, 新生儿, 联合筛查

Abstract: Primary immunodeficiency disease (PID) and spinal muscular atrophy (SMA) are genetic birth defects caused by gene mutations that seriously affect children's health and even lead to death.Early detection,timely diagnosis and treatment are the key to better prognosis.Neonatal screening is an effective means to achieve early diagnosis and intervention.In recent years,neonatal screening in some countries and regions have included SMA,severe combined immunodeficiency disease (SCID) (the most severe disease of PID) and X-linked aglobulinemia (XLA) (the most common B-cell deficiency disease of PID).Zhejiang province is the first in China to carry out neonatal combined screening for SCID,XLA and SMA,which has greatly increased screening efficiency,advanced tertiary prevention of birth defects,significantly improved the prognosis of patients,enhanced their quality of life and reduced mortality.

Key words: primary immunodeficiency disease, severe combined immunodeficiency, X-linked agammaglobulinemia, spinal muscular atrophy, newborns, combined screening

中图分类号:

R725.9

杨茹莱. 原发性免疫缺陷病和脊髓性肌萎缩症临床特点及新生儿早期联合筛查实践[J]. 中国儿童保健杂志, 2022, 30(7): 697-701.

YANG Ru-lai. Clinical characteristics and neonatal early combined screening practice of primary immunodeficiency disease and spinal muscular atrophy[J]. Chinese Journal of Child Health Care, 2022, 30(7): 697-701.

参考文献

[1] 孙丽雅,邢清和,贺林.中国出生缺陷遗传学研究的回顾与展望[J].遗传,2018,40(10):800-813.
[2] King JR,Hammarstrom L.Newborn screening for primary immunodeficiency diseases:History,current and future practice[J].J Clin Immunol,2018,38(1):56-66.
[3] Kumrah R,Vignesh P,Patra P,et al.Genetics of severe combined immunodeficiency[J].Genes Dis,2020,7(1):52-61.
[4] 陈同辛,金莹莹,原发性重症联合免疫缺陷病[J].实用儿科临床杂志,2010,25(9):621-623.
[5] 陈静.可治性罕见病[M].上海:上海交通大学出版社2017.179-185.
[6] 杨锡强,赵晓东.中国原发性免疫缺陷病现状和展望[J].中国实用儿科杂志,2011,26(11):801-804.
[7] El-Sayed ZA,Abramova I,Aldave JC,et al.X-linked agammaglobulinemia (XLA):Phenotype,diagnosis,and therapeutic challenges around the world[J].World Allergy Organ 2019,12(3):100018.
[8] Saffari A,Kolker S,Hoffmann GF,et al.Novel challenges in spinal muscular atrophy-How to screen and whom to treat?[J].Ann Clin Transl Neur 2019,6(1):197-205.
[9] Zhang JJ,Wang YG,Ma DY,et al.Carrier screening and prenatal diagnosis for spinal muscular atrophy in 13,069 Chinese pregnant women[J].J Mol Diagn, 2020,22(6):817-822.
[10] 北京医学会医学遗传学分会,北京罕见病诊疗与保障学会.脊髓性肌萎缩症遗传学诊断专家共识[J].中华医学杂志 2020,100(40):3130-3140.
[11] Pai SY,Logan BR,Griffith LM et al Transplantation outcomes for severe combined immunodeficiency,2000-2009[J].New Engl J Med,2014,371(5):434-446.
[12] Mercuri E,Finkel RS,Muntoni F,et al.Diagnosis and management of spinal muscular atrophy:Part 1:Recommendations for diagnosis,rehabilitation,orthopedic and nutritional care[J].Neuromuscular Disord,2018,28(2):103-115.
[13] Singh A,Jain M,Kapadia R,et al.Review of therapeutic options for spinal muscular atrophy[J].Scripta Medica,2021,52(2):151-159.
[14] Shaw G.Risdiplam Shows Strong Efficacy in infants with type 1 spinal muscular atrophy[J].Neurology Today,2021,21.
[15] Darras BT,Masson R,Mazurkiewicz-Beldzinska M,et al.Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls[J].New Engl J Med,2021,385(5):427-435.
[16] Sansone VA,De Vivo DC,Bertini E,et al,Nusinersen in infants who initiate treatment in a presymptomatic stage of Spinal Muscular Atrophy (SMA):Interim results from the phase 2 NURTURE study[J].Eur J Neurol,2019,26:83-83.
[17] Fischer A,Hacein-Bey-Abina S.Gene therapy for severe combined immunodeficiencies and beyond[J].J Exp Med,2020,217(2):e20190607.
[18] Ludolph AC,Wurster CD.Therapeutic advances in SMA[J].Curr Opin Neurol,2019,32(5):777-781.
[19] Chiarini M,Zanotti C,Serana F,et al.T-cellreceptor and k-deleting recombination excision circles in newborn screening of t-and b-cell defects:Review of the literature and future challenges[J].J Public Health Res,2013,2(1):9-16.
[20] 周文浩,赵正言.基因组测序技术应用于新生儿筛查:临床实践的机遇和挑战[J].中华儿科杂志,2021,59(7):541-544.
[21] Kwan A,Church JA,Cowan MJ,et al.Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California:Results of the first 2 years[J].J Allergy Clin Immun,2013,132(1):140-150.
[22] Nourizadeh M,Shakerian L,Borte S,et al.Newborn screening using TREC/KREC assay for severe T and B cell lymphopenia in Iran[J].Scand J Immunol,2018,88(2):e12699.
[23] Gutierrez-Mateo C,Timonen A,Vaahtera K,at al.Development of a multiplex real-time PCR assay for the newborn screening of SCID,SMA,and XLA[J].Int J Neonat Screen,2019,5(4):412-419.
[24] Morna Dorsey,Jennifer Puck,Newborn Screeningfor severe combined immunodeficiency in the US:Current states and approach to management[J]Int J Neonatal Screen,2017,15:1-10.
[25] Fabie NAV,Pappas KB,Feldman GL.The current state of newborn screening in the United States[J].Pediatr Clin North Am,2019,66(2):369-386.
[26] Loeber JG,Platis D,Zetterstrom RH,et al.Neonatal screening in europe revisited:An ISNS perspective on the current state and developments since 2010[J].Int J Neonatal Screen,2021,7(1):15.
[27] Gongrich C,Ekwall O,Sundin M,et al.First year of TREC-Based National SCID screening in Sweden[J].Int J Neonatal Screen,2021,7(3):59.
[28] Zetterström RH,Barbaro M,Ohlsson A,at al.Newbornscreening for primary immune deficiencies with a trec/krec/actb triplex assay-a three-year pilot study in sweden[J].International Journal of Neonatal Screening,2017,3(2):11.
[29] Audrain MAP,Leger AJC,Hemont CAF,at al.Newbornscreening for severe combined immunodeficiency:Analytic and clinical performance of the t cell receptor excision circle assay in France (DEPISTREC Study)[J].J Clin Immunol,2018,38(7):778-786.
[30] Argudo-Ramirez A,Martin-Nalda A,Marin-Soria JL,at al.Firstuniversal newborn screening program for severe combined immunodeficiency in europe.two-years' experience in catalonia (Spain)[J].Front Immunol,2019,10:2406.
[31] 文旻,王晓川.原发性免疫缺陷病新生儿筛查[J].中国实用儿科杂志,2017,32(7):484-487.
[32] 张志勇,安云飞,蒋利萍,等.中国儿童原发性免疫缺陷病疾病分布、临床特征和分子特点的单中心研究[C]// 中华医学会第十七次全国儿科学术大会论文汇编(上册).2012.

原发性免疫缺陷病和脊髓性肌萎缩症临床特点及新生儿早期联合筛查实践

Clinical characteristics and neonatal early combined screening practice of primary immunodeficiency disease and spinal muscular atrophy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	韦萍, 韦霁珊, 黄旭华, 张宇星, 刘湘红, 何仲彪, 莫靖媛, 黄增帅, 玉群. 心脏听诊、血氧饱和度检测联合吸氧情况在广西新生儿先天性心脏病筛查中的应用[J]. 中国儿童保健杂志, 2024, 32(9): 1034-1039.
[2]	刘畅, 张立琴, 杜玮, 刘婷廷. 2023年美国儿科学会先天性甲状腺功能减低症筛查与管理指南解读[J]. 中国儿童保健杂志, 2024, 32(6): 637-642.
[3]	卢凌亚, 程薇, 吕兰秋. 宁波市2017—2021年儿童先心病流行特征和趋势研究[J]. 中国儿童保健杂志, 2024, 32(2): 202-207.
[4]	崔鹏源, 李贵平. 孟德尔随机化法探究新生儿高胆红素血症与抽动障碍的因果关联[J]. 中国儿童保健杂志, 2024, 32(10): 1116-1121.
[5]	滕云飞, 段钊, 张婷婷, 王惠萍, 乞艳华, 郭琳琼, 李小鹏. 脐膨出畸形胎儿的妊娠结局及发育随访[J]. 中国儿童保健杂志, 2024, 32(10): 1145-1148.
[6]	韦菊芳, 陈吉健. 2015—2021年南宁市西乡塘区新生儿低出生体重变化趋势及影响因素分析[J]. 中国儿童保健杂志, 2023, 31(7): 785-789.
[7]	张雪怡, 张亚昱, 李佳. 微塑料对新生儿健康影响的研究[J]. 中国儿童保健杂志, 2023, 31(4): 399-403.
[8]	彭莘越, 薛洋, 单玲, 贾飞勇, 杜琳. 脊髓性肌萎缩症儿童神经心理发育水平特点[J]. 中国儿童保健杂志, 2023, 31(2): 195-199.
[9]	张娟娟, 马金旗, 曾军安, 何阿玲. 新生儿遗传性出血性毛细血管扩张症1例并文献回顾[J]. 中国儿童保健杂志, 2023, 31(2): 225-228.
[10]	武童, 冀红. 高氧与未成熟脑损伤的研究进展[J]. 中国儿童保健杂志, 2023, 31(11): 1214-1218.
[11]	张笃飞, 张湘云. 海南省2020年新生儿先天性心脏病的流行病学调查[J]. 中国儿童保健杂志, 2023, 31(1): 91-95.
[12]	王惠萍, 王莉, 高琼, 白铂亮, 马颖君. 极低出生体重坏死性小肠结肠炎患儿体格及神经发育的研究[J]. 中国儿童保健杂志, 2023, 31(1): 96-100.
[13]	袁源, 陈密. 脐带血miR-431表达水平与新生儿先天性听力障碍关系的研究[J]. 中国儿童保健杂志, 2023, 31(1): 101-104.
[14]	刘俐, 魏思萌, 姜忒. 新生儿营养与儿童早期发展[J]. 中国儿童保健杂志, 2022, 30(8): 879-883.
[15]	周春明, 陈土容, 陈艺, 曹建国. 脊髓性肌萎缩症的运动功能评估及临床研究进展[J]. 中国儿童保健杂志, 2022, 30(7): 741-745.